BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ahmadi Rastegar D, Dzamko N. Leucine Rich Repeat Kinase 2 and Innate Immunity. Front Neurosci 2020;14:193. [PMID: 32210756 DOI: 10.3389/fnins.2020.00193] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
Number Citing Articles
1 Bonet-Ponce L, Cookson MR. LRRK2 recruitment, activity, and function in organelles. FEBS J 2021. [PMID: 34196120 DOI: 10.1111/febs.16099] [Reference Citation Analysis]
2 Ahmadi Rastegar D, Hughes LP, Perera G, Keshiya S, Zhong S, Gao J, Halliday GM, Schüle B, Dzamko N. Effect of LRRK2 protein and activity on stimulated cytokines in human monocytes and macrophages. NPJ Parkinsons Dis 2022;8:34. [PMID: 35347144 DOI: 10.1038/s41531-022-00297-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Wu R, Farrer MJ. Parkinson disease risk variants in East Asian populations. Nat Rev Neurol 2020;16:461-2. [DOI: 10.1038/s41582-020-0379-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Russo I, Bubacco L, Greggio E. LRRK2 as a target for modulating immune system responses. Neurobiology of Disease 2022. [DOI: 10.1016/j.nbd.2022.105724] [Reference Citation Analysis]
5 Menozzi E, Macnaughtan J, Schapira AHV. LRRK2 Parkinsonism: Does the Response to Gut Bacteria Mitigate the Neurological Picture? Mov Disord 2021;36:71-5. [PMID: 33107648 DOI: 10.1002/mds.28347] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Li Y, Chen Y, Jiang L, Zhang J, Tong X, Chen D, Le W. Intestinal Inflammation and Parkinson's Disease. Aging Dis 2021;12:2052-68. [PMID: 34881085 DOI: 10.14336/AD.2021.0418] [Reference Citation Analysis]
7 Xu E, Boddu R, Abdelmotilib HA, Sokratian A, Kelly K, Liu Z, Bryant N, Chandra S, Carlisle SM, Lefkowitz EJ, Harms AS, Benveniste EN, Yacoubian TA, Volpicelli-Daley LA, Standaert DG, West AB. Pathological α-synuclein recruits LRRK2 expressing pro-inflammatory monocytes to the brain. Mol Neurodegener 2022;17:7. [PMID: 35012605 DOI: 10.1186/s13024-021-00509-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
8 Eng VV, Wemyss MA, Pearson JS. The diverse roles of RIP kinases in host-pathogen interactions. Semin Cell Dev Biol 2021;109:125-43. [PMID: 32859501 DOI: 10.1016/j.semcdb.2020.08.005] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
9 Herrick MK, Tansey MG. Is LRRK2 the missing link between inflammatory bowel disease and Parkinson's disease? NPJ Parkinsons Dis 2021;7:26. [PMID: 33750819 DOI: 10.1038/s41531-021-00170-1] [Reference Citation Analysis]
10 Sanchez-burgos L, Gómez-lópez G, Al-shahrour F, Fernandez-capetillo O. An in silico analysis identifies drugs potentially modulating the cytokine storm triggered by SARS-CoV-2 infection. Sci Rep 2022;12. [DOI: 10.1038/s41598-022-05597-x] [Reference Citation Analysis]
11 García-García R, Martín-Herrero L, Blanca-Pariente L, Pérez-Cabello J, Roodveldt C. Immune Signaling Kinases in Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Int J Mol Sci 2021;22:13280. [PMID: 34948077 DOI: 10.3390/ijms222413280] [Reference Citation Analysis]
12 Chittoor-Vinod VG, Nichols RJ, Schüle B. Genetic and Environmental Factors Influence the Pleomorphy of LRRK2 Parkinsonism. Int J Mol Sci 2021;22:1045. [PMID: 33494262 DOI: 10.3390/ijms22031045] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
13 Colli ML, Szymczak F, Eizirik DL. Molecular Footprints of the Immune Assault on Pancreatic Beta Cells in Type 1 Diabetes. Front Endocrinol (Lausanne) 2020;11:568446. [PMID: 33042023 DOI: 10.3389/fendo.2020.568446] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
14 Henderson MX, Changolkar L, Trojanowski JQ, Lee VMY. LRRK2 Kinase Activity Does Not Alter Cell-Autonomous Tau Pathology Development in Primary Neurons. J Parkinsons Dis 2021;11:1187-96. [PMID: 33720852 DOI: 10.3233/JPD-212562] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
15 Mahmoudi E, Mozhgani SH, Sharifinejad N. The role of mycobiota-genotype association in inflammatory bowel diseases: a narrative review. Gut Pathog 2021;13:31. [PMID: 33964975 DOI: 10.1186/s13099-021-00426-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
16 Nazish I, Arber C, Piers TM, Warner TT, Hardy JA, Lewis PA, Pocock JM, Bandopadhyay R. Abrogation of LRRK2 dependent Rab10 phosphorylation with TLR4 activation and alterations in evoked cytokine release in immune cells. Neurochem Int 2021;147:105070. [PMID: 34004238 DOI: 10.1016/j.neuint.2021.105070] [Cited by in F6Publishing: 1] [Reference Citation Analysis]